564 related articles for article (PubMed ID: 19637415)
1. Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes.
Prescrire Int; 2009 Jun; 18(101):104. PubMed ID: 19637415
[TBL] [Abstract][Full Text] [Related]
2. [New treatment options for HIV-infected patients].
Wehr A
Dtsch Med Wochenschr; 2004 May; 129(19):1093. PubMed ID: 15174468
[No Abstract] [Full Text] [Related]
3. [Are all boosted protease inhibitors the same? Previously treated patients profit too from lopinavir/r].
MMW Fortschr Med; 2003 Dec; 145(50):61. PubMed ID: 14963981
[No Abstract] [Full Text] [Related]
4. Drug interactions. Kaletra and atazanavir.
TreatmentUpdate; 2006; 18(3):7-8. PubMed ID: 17211919
[No Abstract] [Full Text] [Related]
5. The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.
Chetchotisakd P
Expert Rev Anti Infect Ther; 2009 Sep; 7(7):801-5. PubMed ID: 19735222
[TBL] [Abstract][Full Text] [Related]
6. 96-week CASTLE data show similar efficacy results.
AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
[No Abstract] [Full Text] [Related]
7. [Efficacy of atazanavir in treatment-naive patients].
Moreno S; Hernández B; Dronda F
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():9-13. PubMed ID: 20116611
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial.
Soriano V; García-Gasco P; Vispo E; Ruiz-Sancho A; Blanco F; Martín-Carbonero L; Rodríguez-Novoa S; Morello J; de Mendoza C; Rivas P; Barreiro P; González-Lahoz J
J Antimicrob Chemother; 2008 Jan; 61(1):200-5. PubMed ID: 17999977
[TBL] [Abstract][Full Text] [Related]
9. Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study.
Molina JM; Andrade-Villanueva J; Echevarria J; Chetchotisakd P; Corral J; David N; Moyle G; Mancini M; Percival L; Yang R; Thiry A; McGrath D;
Lancet; 2008 Aug; 372(9639):646-55. PubMed ID: 18722869
[TBL] [Abstract][Full Text] [Related]
10. [Atazanavir protects lipid metabolism. New PI with favorable metabolic profile].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():90. PubMed ID: 15373065
[No Abstract] [Full Text] [Related]
11. CASTLE study showed similar efficacy.
AIDS Patient Care STDS; 2008 Mar; 22(3):253. PubMed ID: 18348342
[No Abstract] [Full Text] [Related]
12. [Clinical utility of atazanavir].
Ribera Pascuet E; Curran A
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():55-67. PubMed ID: 20116619
[TBL] [Abstract][Full Text] [Related]
13. A king in the CASTLE? Optimum initial HIV protease inhibitor.
Torti C; Frank I
Lancet; 2008 Aug; 372(9639):604-6. PubMed ID: 18722849
[No Abstract] [Full Text] [Related]
14. Anti-HIV agents. Kaletra + atazanavir.
TreatmentUpdate; 2005; 17(5):5. PubMed ID: 17219657
[No Abstract] [Full Text] [Related]
15. [Efficacy of atazanavir in simplification regimens].
Zamora L; Gatell JM
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():14-21. PubMed ID: 20116612
[TBL] [Abstract][Full Text] [Related]
16. [Adverse effects of atazanavir].
Palacios R; González M; Ruiz J; Santos J
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():41-4. PubMed ID: 20116616
[TBL] [Abstract][Full Text] [Related]
17. Atazanavir in children.
Prescrire Int; 2011; 20(118):177. PubMed ID: 21751749
[No Abstract] [Full Text] [Related]
18. Lopinavir + ritonavir tablets: new formulation. More convenient, but minimal evaluation.
Prescrire Int; 2007 Aug; 16(90):148. PubMed ID: 17724839
[TBL] [Abstract][Full Text] [Related]
19. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
Ly T; Ruiz ME
Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of atazanavir in rescue therapy].
Portilla J; Boix V; Merino E; Reus S
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():22-7. PubMed ID: 20116613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
